Endonovo Therapeutics Announces Second Quarter Results
13 août 2019 13h39 HE
|
Endonovo Therapeutics Inc.
LOS ANGELES, Aug. 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announces financial and operating results for the...
Endonovo Therapeutics Appoints Dr. Steven Levin of Johns Hopkins University to Its Scientific Advisory Board
21 juin 2019 09h22 HE
|
Endonovo Therapeutics Inc.
WOODLAND HILLS, Calif., June 21, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive...
Endonovo Therapeutics Announces New Website Launch
27 févr. 2019 08h00 HE
|
Endonovo Therapeutics, Inc.
The completely redesigned website offers visitors deeper insight into the Company's core product, SofPulse® LOS ANGELES, CA, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB:...
Endonovo Therapeutics Files Lawsuit against KVP International Inc., Orthocor Medical Inc., and Careus Corp. for Patent Infringement
08 févr. 2019 08h00 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...
Endonovo Therapeutics Issues Shareholder Letter and Update
11 janv. 2019 09h15 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...